Oncternal Therapeutics Inc ONCT Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Oncternal Therapeutics Inc (ONCT)
Oncternal Therapeutics Inc (ONCT) Financials

Oncternal Therapeutics Inc (ONCT)

0.71

-0.43

(-37.72%)

Closed 26 November 8:00AM

Delayed by 15 minutes

0.72

0.01

(1.41%)

After Hours: 11:59AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-62.703	-86.061	-99.07	-128.853	-24.51	-29.505	-54.452	-74.927
Return on Equity (%)	-162.979	-104.688	-119.362	-169.151	-27.07	-31.166	-59.253	-86.747
Return on Invested Capital (%)	-238.464	-105.431	-121.354	-166.976	-27.904	-31.421	-61.087	-93.388
Operating Margin (%)	N/A	N/A	N/A	-1409.814	-510.37	-726.141	-2964.43	-5029.172
Net Profit Margin (%)	N/A	N/A	N/A	-1409.814	-510.37	-726.141	-2964.43	-5029.172
Book Value Per Share	1.242	1.771	1.082	0.93	2.314	1.783	1.061	0.51
Earnings Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
Cash Per Share	0.56	0.734	1.175	1.303	2.392	1.836	0.646	0.114
Working Capital Per Share	1.237	1.769	1.081	0.874	2.298	1.768	1.037	0.523
Operating Profit Per Share	N/A	N/A	N/A	0.158	0.069	0.087	0.026	0.013
EBIT Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
EBITDA Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
Free Cash Flow Per Share	-1.109	-1.414	-1.599	-2.222	-0.353	-0.634	-0.769	-0.669

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	15.92M	21.54M	24.05M	15.39M	48.8M	49.43M	57.46M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	55.52M	57.46M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-5658.621	N/A	N/A	N/A	-1474.165	N/A
Net Profit Margin (%)	N/A	N/A	-5658.621	N/A	N/A	N/A	-1474.165	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	3.37M
Price to Earnings Ratio	-0.05
Price to Sales Ratio	2.75
Price to Cash Ratio	0.32
Price to Book Ratio	0.07
Dividend Yield	-

Share Statistics

Shares Outstanding	2.96M
Average Volume (1 week)	32.59k
Average Volume (1 Month)	85.28k
52 Week Change	-89.41%
52 Week High	13.14
52 Week Low	1.03

More Ratios Coming Soon!

Oncternal Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions